Pharmaceuticals
Celgene to buy drugmaker Receptos for $7.2 bn
15 Jul 2015
Ireland’s Horizon Pharma launches $3-bn hostile buyout bid for US rival Depomed
08 Jul 2015
The combined entity will have 13 marketed drugs, which nearly doubles Horizon’s current portfolio of seven,and is expected to result in 2015 net sales of over $950 million
Teva plans to raise bid for rival drugmaker Mylan to $42 bn
07 Jul 2015
Teva and Mylan's product offerings are highly complementary and, together, would create the broadest portfolio in the global pharmaceuticals industry, with a combined pipeline of over 400 applications for new drugs
Biogen ventures into ophthalmology with $1-bn AGTC tie-up
04 Jul 2015
The collaboration will focus on the development of a portfolio of therapeutic programmes for orphan diseases of the retina that can lead to blindness in children and adults
.webp)
